MOTTOLA FRANK (Sr VP, Quality, GMP Oper. & IT) reported 3 transactions at SUPERNUS PHARMACEUTICALS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 3/5/2025ACC: 0001628280-25-010472
Officer· Sr VP, Quality, GMP Oper. & IT
Since Feb 2020
-1.89K
Net shares
Net seller
$62.5K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
1.89K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−337.00
Price / share
$33.05
Trade value
$11.14K
% of position
2.1%
3/5/2025
15.77K→15.44K
Common Stock
Direct
Shares
−610.00
Price / share
$33.05
Trade value
$20.16K
% of position
4.0%
3/5/2025
15.44K→14.83K
Common Stock
Direct
Shares
−945.00
Price / share
$33.05
Trade value
$31.23K
% of position
6.4%
3/5/2025
14.83K→13.88K
Total
Net shares
−1.89K
Net value
-$62.53K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/5/2025 | F · Tax Withholding | −337.00 | $33.05 | $11.14K | 2.1% | 15.77K | 15.44K |
| Common Stock Direct | 3/5/2025 | F · Tax Withholding | −610.00 | $33.05 | $20.16K | 4.0% | 15.44K | 14.83K |
| Common Stock Direct | 3/5/2025 | F · Tax Withholding | −945.00 | $33.05 | $31.23K | 6.4% | 14.83K | 13.88K |
| Total | −1.89K | -$62.53K | ||||||
Derivative Transactions0
No derivative transactions reported